KAYDE MOORE: Open Payments
NPI 1891184453 · BRUNSWICK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,673 in 203 payments from 50 companies in 2025. Trend: 2023 $3,960 · 2024 $5,124 · 2025 $4,673
Food & beverage: $4,294Education: $431
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $478 |
| Janssen Biotech, Inc. | 11 | $372 |
| Merck Sharp & Dohme LLC | 12 | $302 |
| SOBI, INC | 8 | $226 |
| Incyte Corporation | 7 | $226 |
| PFIZER INC. | 11 | $205 |
| E.R. Squibb & Sons, L.L.C. | 9 | $166 |
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| Gilead Sciences, Inc. | 6 | $122 |
| ABBVIE INC. | 6 | $121 |
Products named: KEYTRUDA, IMFINZI, RYBREVANT, ENHERTU, Vonjo, OPDIVO, Trodelvy, LONSURF.
Industry payments across GA — which companies pay providers there.
